Aug. 6 at 8:27 PM
$PBYI Q2 '26 Earnings Results & Recap
• Reported GAAP EPS of
$0.16 up 33.33% YoY
• Reported revenue of
$56.5M up 7.75% YoY
• Puma Biotechnology raised its full year 2026 guidance, now anticipating net product revenue of
$205-
$209 million, total revenue of
$224-
$231 million, and net income in the range of
$17-
$20 million.
